Human trials of experimental AIDS vaccines: recombinant envelope proteins.
Snart
R S
RS
Département de Physiologie Cellulaire, Université Pierre et Marie Curie, Paris, France.
D000163:Acquired Immunodeficiency Syndrome / Q000276:immunology / Q000517:prevention & control*; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D002986:Clinical Trials as Topic; D015483:HIV Antibodies / Q000096:biosynthesis; D015488:HIV Antigens; D015497:HIV-1 / Q000276:immunology; D006801:Humans; D011994:Recombinant Proteins / Q000276:immunology; D012191:Retroviridae Proteins / Q000276:immunology*; D014759:Viral Envelope Proteins / Q000276:immunology*; D014765:Viral Vaccines / Q000627:therapeutic use*
D015483:HIV Antibodies; D015488:HIV Antigens; D011994:Recombinant Proteins; D012191:Retroviridae Proteins; D014759:Viral Envelope Proteins; D014765:Viral Vaccines